| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/21/2005 | US20050159491 Cerebrovascular and cardiovascular diseases; hot water extracting danshen plant and chromatographic separation on polyamide column; high yield, low cost, quality |
| 07/21/2005 | US20050159481 4,6-di-t-butyl-5-hydroxy-2,2-di-n-pentyl-2,3-dihydrobenzofuran; side effect reduction: lowers high-density lipoprotein cholesterol (HDL-C), prolongs electrocardiographic QT intervals; myocardial infarction, hypotensive, antidiabetic, anticoagulant, arteriosclerosis obliterans, intermittent claudication |
| 07/21/2005 | US20050159480 Preparation of statins by reacting (trisubstituted phosphoranylidenecarbonyl)acetates with benzaldehydes, reduction with diamino-group 8 metal coordinates, condensation with 1-hydroxy-1-alkoxyethylenes, hydrolysis, and optionally converting the carboxy acid product into a salt or a lactone |
| 07/21/2005 | US20050159474 Chemical compounds |
| 07/21/2005 | US20050159473 3-Substituted oxindole beta3 agonists |
| 07/21/2005 | US20050159472 Chemical compounds |
| 07/21/2005 | US20050159467 5-Aryltetrazole compounds and uses thereof |
| 07/21/2005 | US20050159466 Production method of isoxazolidinedione compound |
| 07/21/2005 | US20050159463 5-methoxy-3-(2-(2-furamido) ethyl)indole; related to melatonin, but pharmacologicaly and pharmacokineticy different; longer duration, selective localization and greater efficacy |
| 07/21/2005 | US20050159456 Method of treating of demyelinating diseases or conditions |
| 07/21/2005 | US20050159452 Nociceptin analogs |
| 07/21/2005 | US20050159451 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 07/21/2005 | US20050159434 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl)-3-oxo-propionitrile mono citrate salt; immunosuppressants, autoimmune diseases, skin disorders, Crohn's disease, antidiabetic agents, anticancer agents, antiarthritic agents |
| 07/21/2005 | US20050159421 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 07/21/2005 | US20050159418 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders |
| 07/21/2005 | US20050159415 Agents for preventing or ameliorating insulin resistance and /or obesity |
| 07/21/2005 | US20050159402 Polyarylcarboxamides useful as lipid lowering agents |
| 07/21/2005 | US20050159397 vitamin D3 derivative as anti-cancer agent, for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion, for immune disorders, metabolic bone diseases and also used as antiinflammatory agent |
| 07/21/2005 | US20050159359 Methods and compositions for derepression of IAP-inhibited caspase |
| 07/21/2005 | US20050159336 Administering activated lymphocytes; promote nerve regeneration |
| 07/21/2005 | US20050159329 Low reducing sugar content, high level of alpha glucoside bonds, narrow range of high molecular weights, specific branched chain length distribution profile; low intrinsic viscosity; food, and medical applications |
| 07/21/2005 | US20050158771 Using gene expression patterns and skeletal muscle marker as diagnostic tool in detection and prognostication of obesity |
| 07/21/2005 | US20050158724 Methods, of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| 07/21/2005 | US20050158406 Methods for treating joint inflammation |
| 07/21/2005 | US20050158288 Methods of organ regeneration |
| 07/21/2005 | US20050158264 Sympathetic nerve-stimulating fragrant compositions |
| 07/21/2005 | US20050158250 Granulated composition of soluble, powdered insulin and a carrier of aggregated crystalline cellulose; increases a blood insulin concentration |
| 07/21/2005 | US20050158244 Cell population from staining a neoplastic cell population with a first marker, staining a dendritic cell population with a second marker, fusing the cells to obtain hybrid cell population stained with both markers; purifying |
| 07/21/2005 | DE10360835A1 New bicyclic imidazole derivatives are dipeptidylpeptidase-IV inhibitors useful to treat e.g. arthritis, obesity, allograft transplantation and calcitonin-induced osteoporosis |
| 07/21/2005 | CA2552526A1 Glucagon-like peptide-1 analogs with long duration of action |
| 07/21/2005 | CA2550771A1 Malt root of wheat, barley, oats or rye including high functional ingredients contents and their processing methods |
| 07/21/2005 | CA2549396A1 Cb1 modulator compounds |
| 07/21/2005 | CA2549385A1 Triazole, oxadiazole and thiadiazole derivative as ppar modulators for the treatment of diabetes |
| 07/20/2005 | EP1554312A2 Neutralizing antibodies against gdf-8 and uses therefor |
| 07/20/2005 | EP1554286A1 Fused heterocyclic isoxazoline derivatives and their use as anti-depressants |
| 07/20/2005 | EP1554280A2 Antidiabetic beta-amino heterocyclic dipeptidyl peptidase inhibitors |
| 07/20/2005 | EP1554278A2 Xanthine derivatives, production thereof and use thereof as medicines |
| 07/20/2005 | EP1554263A1 N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them |
| 07/20/2005 | EP1554262A1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 07/20/2005 | EP1554259A1 Novel bicyclic inhibitors of hormone sensitive lipase |
| 07/20/2005 | EP1554256A1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 07/20/2005 | EP1554253A1 Imidazolium cxcr3 inhibitors |
| 07/20/2005 | EP1554245A1 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 07/20/2005 | EP1553973A2 eNOS MUTANTS USEFUL FOR GENE THERAPY |
| 07/20/2005 | EP1553969A1 Use of ghrelin for treating malnutrition in gastrectomised individuals |
| 07/20/2005 | EP1553937A2 Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods |
| 07/20/2005 | EP1286673B8 Ligands of integrin receptors |
| 07/20/2005 | EP1284959B1 Compounds for modulating the rage receptor |
| 07/20/2005 | EP1272484B1 Benzoamide piperidine compounds as substance p antagonists |
| 07/20/2005 | EP1244672B1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |
| 07/20/2005 | EP1189583B1 Indole derivatives |
| 07/20/2005 | EP1173408B1 Ppar-(gamma) agonists as agents for the treatment of type ii diabetes |
| 07/20/2005 | EP1129077B9 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors |
| 07/20/2005 | EP0977586B1 Combinations of antigen and mucosal binding component for inducing specific immunological tolerance |
| 07/20/2005 | EP0828851B1 Tripeptidylpeptidase inhibitors |
| 07/20/2005 | EP0721500B1 Insulin-secreting cell lines, methods of production and use |
| 07/20/2005 | CN1643164A Recombinant bovine immunodeficiency virus based gene transfer system |
| 07/20/2005 | CN1643135A Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 07/20/2005 | CN1643134A Method for producing pseudo islets |
| 07/20/2005 | CN1643133A Chimeric pancreas |
| 07/20/2005 | CN1643130A A selenium yeast product, a method of preparing a selenium yeast product and the use of the product for preparing food, a dietary supplement or a drug |
| 07/20/2005 | CN1642983A Antibodies against of C5aR and use thereof |
| 07/20/2005 | CN1642980A Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 07/20/2005 | CN1642965A Crystals of glucopyranosyloxybenzyl benzene derivative |
| 07/20/2005 | CN1642960A Substituted amino isoxazoline derivatives and their use as anti-depressants |
| 07/20/2005 | CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642944A (3Z) -3-(2, 3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 07/20/2005 | CN1642938A New compounds |
| 07/20/2005 | CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642910A Synthesis of indole thiazole compounds as ligands for the AH receptor |
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642904A Salts of nateglinide |
| 07/20/2005 | CN1642599A ACC inhibitors |
| 07/20/2005 | CN1642580A Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 07/20/2005 | CN1642573A Combination of an aldosterone receptor antagonist and a fibric acid derivative |
| 07/20/2005 | CN1642569A Treatment of type I diabetes |
| 07/20/2005 | CN1642559A Combination comprising an HMG-CoA reductase inhibitor and an insulin secretor enhancer or an insulin sensitizer |
| 07/20/2005 | CN1642557A Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative |
| 07/20/2005 | CN1642556A Combination of an aldosterone receptor antagonist and a bile acid sequestering agent |
| 07/20/2005 | CN1642551A Inhibitors of histone deacetylase |
| 07/20/2005 | CN1642543A Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections |
| 07/20/2005 | CN1642542A Angiogenesis inhibitors |
| 07/20/2005 | CN1642528A Stable salts of O-acetylsalicylic acid containing basic amino acids II |
| 07/20/2005 | CN1642526A Formulations of atorvastatin stabilized with alkali metal additions |
| 07/20/2005 | CN1642437A Probiotic delivery system |
| 07/20/2005 | CN1640885A Loguat leaf total dehydrocamphenilic acid and its preparation method and use |
| 07/20/2005 | CN1640488A Method for preparing supermicro powder preparation of cordyceps sinensis mycelium |
| 07/20/2005 | CN1640481A Weight-reducing capsule |
| 07/20/2005 | CN1640470A Medicinal composition, and its preparing method and use |
| 07/20/2005 | CN1640459A Compound soybean nutrient and its preparation |
| 07/20/2005 | CN1640458A Navel-moistening health-care liquor |
| 07/20/2005 | CN1640454A Red-kness leaf tea for hyperglycemia |
| 07/20/2005 | CN1640444A Fresh tea juice preparation and its preparing method |
| 07/20/2005 | CN1640442A Fresh multiflower knotweed tuber preparation and its preparing method |
| 07/20/2005 | CN1640429A Method for extracting effective component from sophora alopecuroide for reducing blood fat and its medicinal use |
| 07/20/2005 | CN1640413A Pearl nourishing health-care vinegar oral liquid and its preparing method |
| 07/20/2005 | CN1640405A Method for producing d-alpha-succinic tocopherol granule |
| 07/20/2005 | CN1640396A Novel medicinal compositions |
| 07/20/2005 | CN1640386A Oral solid medicine release system |
| 07/20/2005 | CN1211492C Method for preparing easy body absorption protein-calcium by enzyme and health food produced by said protein-calcium |